These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8720744)
1. Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword? Niskanen L Drugs Aging; 1996 Mar; 8(3):183-92. PubMed ID: 8720744 [TBL] [Abstract][Full Text] [Related]
2. Management of type 2 diabetes mellitus in the elderly: special considerations. Rosenstock J Drugs Aging; 2001; 18(1):31-44. PubMed ID: 11232737 [TBL] [Abstract][Full Text] [Related]
3. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Wolffenbuttel BH; van Haeften TW Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759 [TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
5. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus. Jennings PE Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853 [TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
7. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Dunn CJ; Peters DH Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013 [TBL] [Abstract][Full Text] [Related]
8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
10. Oral antidiabetic drug use in the elderly. Bressler R; Johnson DG Drugs Aging; 1996 Dec; 9(6):418-37. PubMed ID: 8972242 [TBL] [Abstract][Full Text] [Related]
11. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review. Ilarde A; Tuck M Drugs Aging; 1994 Jun; 4(6):470-91. PubMed ID: 8075474 [TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus. Evans A; Krentz AJ Drug Saf; 1999 Jul; 21(1):7-22. PubMed ID: 10433350 [TBL] [Abstract][Full Text] [Related]
13. Treatment of NIDDM with insulin agonists or substitutes. Galloway JA Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453 [TBL] [Abstract][Full Text] [Related]
14. Optimising therapy for insulin-treated type 2 diabetes mellitus. Hermann LS Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006 [TBL] [Abstract][Full Text] [Related]
15. Insulin: either alone or combined with oral hypoglycemic agents. Firth RG Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969 [TBL] [Abstract][Full Text] [Related]
16. Non-insulin dependent diabetes--the past, present and future. Gorden P Ann Acad Med Singap; 1997 May; 26(3):326-30. PubMed ID: 9285027 [TBL] [Abstract][Full Text] [Related]
17. Antihyperglycaemic agents. Drug interactions of clinical importance. Scheen AJ; Lefèbvre PJ Drug Saf; 1995 Jan; 12(1):32-45. PubMed ID: 7741982 [TBL] [Abstract][Full Text] [Related]